Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-05 2024-06-07 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-01-30 230958
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-02-06 230961
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-11 2025-02-20 232747
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-23 2025-03-04 248445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-03-27 250909
TEVA-BUSPIRONE 10MG TABLET Resolved 2024-04-25 2025-03-13 226174

Showing 881 to 900 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818

Showing 61 to 80 of 299